Clinical Trial Update: Impact of Nuedexta on Bulbar Physiology and Function in ALS [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the impact of Nuedexta on bulbar physiology and function in amyotrophic lateral sclerosis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: University of Florida | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-08